G61A (p.Gly61Ala) variant of KRT1 (Keratin, type II cytoskeletal 1)

G61A (p.Gly61Ala) in KRT1 (Keratin, type II cytoskeletal 1) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes population frequency data and structural context.

G61A (p.Gly61Ala) variant details